[Summary of our clinical experience with the determination of serum prostate-specific antigen level in the first five years].
The authors determined serum PSA levels in combination with digital rectal examination (DRE) and evaluated their role in the differential diagnosis of prostate diseases with special reference to cancer. The possible causes of differences between the observed cut-off level of PSA and the standard level PSA were analyzed. In the last few years the PSA determination found its clinical role in the diagnosis of prostate cancer.
Bánfi
Gergely
G
Urológiai Klinika, Semmelweis Egyetem, Budapest, Hungary. banfigergely@freemail.hu
Kiss
Ferenc
F
Kádár
Anna
A
Romics
Imre
I
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D014408:Biomarkers, Tumor / Q000097:blood*; D001707:Biopsy, Needle; D002277:Carcinoma / Q000175:diagnosis* / Q000276:immunology / Q000473:pathology; D006801:Humans; D008297:Male; D008875:Middle Aged; D011237:Predictive Value of Tests; D017430:Prostate-Specific Antigen / Q000097:blood*; D011470:Prostatic Hyperplasia / Q000175:diagnosis; D011471:Prostatic Neoplasms / Q000175:diagnosis* / Q000276:immunology / Q000473:pathology; D011472:Prostatitis / Q000175:diagnosis; D012189:Retrospective Studies
D014408:Biomarkers, Tumor; D017430:Prostate-Specific Antigen
A prosztataspecifikus antigén-szint meghatározásának elsô öt éve során szerzett tapasztalataink összefoglalása.